Compare WNW & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WNW | COCH |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Blank Checks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 24.4M |
| IPO Year | 2020 | N/A |
| Metric | WNW | COCH |
|---|---|---|
| Price | $1.78 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 32.2K | ★ 123.6K |
| Earning Date | 05-12-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $2,550,178.00 | $208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.00 |
| P/E Ratio | $1.32 | ★ N/A |
| Revenue Growth | ★ 570.49 | N/A |
| 52 Week Low | $0.95 | $0.64 |
| 52 Week High | $6.66 | $1.91 |
| Indicator | WNW | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 43.24 |
| Support Level | $1.40 | $0.64 |
| Resistance Level | $1.56 | $0.70 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 84.64 | 30.89 |
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.